• Home
  • Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series.

Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series.

Author List
Kambhampati S, Gray L, Fakhri B, Lo M, Vu K, Arora S, Kaplan L, Ai WZ, Andreadis C
Publication
Clinical lymphoma, myeloma & leukemia
Publication ID (Profile URL)
https://researcherprofiles.org/profile/88521719
Publication Year
2019
PubMed ID
31948859
Publication Title
Kambhampati S, Gray L, Fakhri B, Lo M, Vu K, Arora S, Kaplan L, Ai WZ, Andreadis C. Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series. Clin Lymphoma Myeloma Leuk. 2020 03; 20(3):e118-e123.